|
|
Pfizer Inc CDR
TSX •
Healthcare •
Drug Manufacturers - General •
Quote as of 10/30/2026
Company Profile
IndustryDrug Manufacturers - General
SectorHealthcare
ExchangeTSX
Market Capitalization223,063 mln
Float16,781 mln
Earnings Date11/03/2026
Relative Strength
87
/ 100
Strongly outperforming
Key Fundamentals
EPS0.33
P/E41.00
ROE4.89
ROIC9.34
ROA2.10
Interest Cover6.27
EBITDA, mln18,574
EV / EBITDA16.43
EV / EBIT32.09
Revenue, mln88,051
EV / Revenue3.48
Quote Details
Last
13.53
Change
0.24 (1.81%)
Open
13.44
Volume
109,532
Turnover
1,481,968
Average Volume
118,560
Financial Ratios
Pre-Tax Profit Margin7
Leverage Ratio2.36
Current Ratio1.27
Price / Book1.99
Price / Cash Flow12.74
Price / Free Cash Flow15.48
Debt / Equity0.74
Price / Sales2.67
Financial Strength
Altman Z-Score2.14
Piotroski F-Score
6
/ 9
Beneish M-Score-2.63
Price to Intrinsic Value0.79
Shiller PE Ratio10.53
Price Performance & Relative Strength
| Period |
Price Performance |
Relative Strength |
| 1 Week |
1.58% |
85
/ 100
 |
| 1 Month |
6.54% |
88
/ 100
|
| 2 Months |
23% |
95
/ 100
 |
| 6 Months |
16.47% |
86
/ 100
|
|
| |
